1 |
Bruton's tyrosine kinase
(1851 times)
|
Neoplasms (331 times)
|
CLL (264 times) BCR (233 times) XLA (218 times)
|
1993 The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
|
2 |
below-the-knee
(148 times)
|
Vascular Diseases (93 times)
|
CLI (53 times) PTA (21 times) PAD (19 times)
|
2005 Below-the-knee angioplasty in patients with end-stage renal disease.
|
3 |
behind-the-knee
(9 times)
|
Dermatology (7 times)
|
HRIPT (2 times) TEWL (2 times) AF (1 time)
|
2006 Correlating sensory effects with irritation.
|
4 |
Bruton's kinase
(8 times)
|
Neoplasms (3 times)
|
CLL (3 times) AF (1 time) AIHA (1 time)
|
2016 Autoimmune hemolytic anemia (AIHA) associated with chronic lymphocytic leukemia in the current era of targeted therapy.
|
5 |
Blonder-Tinkham-Klapwijk
(6 times)
|
Nanotechnology (4 times)
|
AR (2 times) PCAR (2 times) FEBID (1 time)
|
2002 Spin-dependent transparency of ferromagnet/superconductor interfaces.
|
6 |
Bruton tyrosine kinase inhibitor
(5 times)
|
Neoplasms (3 times)
|
CLL (4 times) PI3K (2 times) BTKs (1 time)
|
2016 [New insights in the treatment of chronic lymphocytic leukemia and role of the biologist in the monitoring of the treatments].
|
7 |
below-the-knee arteries
(3 times)
|
Hypertension (1 time)
|
AFS (1 time) ASA (1 time) CD-TLR (1 time)
|
2015 Impact of uncontrolled hypertension on 12-month clinical outcomes following below-the-knee arteries (BTK) interventions in patients with critical limb ischemia.
|
8 |
Biotronik
(2 times)
|
Cardiology (2 times)
|
GDT (2 times) CIEDs (1 time) CRT-D (1 time)
|
2010 Ventricular oversensing due to manufacturer-related differences in implantable cardioverter-defibrillator signal processing and sensing lead properties.
|
9 |
Bruton's TK
(2 times)
|
Pharmacology (1 time)
|
xid (1 time)
|
2014 Bruton's TK inhibitors: structural insights and evolution of clinical candidates.
|
10 |
5-O-benzoylated taxinine K
(1 time)
|
Molecular Biology (1 time)
|
MRP (1 time) P-gp (1 time) VCR (1 time)
|
2000 Reversal of P-glycoprotein and multidrug-resistance protein-mediated drug resistance in KB cells by 5-O-benzoylated taxinine K.
|
11 |
B-cell tyrosine kinase
(1 time)
|
Skin Diseases (1 time)
|
PG (1 time) XLA (1 time)
|
2017 Pyoderma Gangrenosum in a Patient with X-Linked Agammaglobulinemia.
|
12 |
B-lymphocytic kinase
(1 time)
|
Pharmacology (1 time)
|
ALK (1 time) PTK (1 time)
|
2022 Target Specific Inhibition of Protein Tyrosine Kinase in Conjunction With Cancer and SARS-COV-2 by Olive Nutraceuticals.
|
13 |
Barrett True K
(1 time)
|
|
APP (1 time) BTKNH (1 time) PVP (1 time)
|
2019 Intraocular Lens Calculation after Refractive Surgery: A Long-Term Retrospective Comparison of Eight Formulas.
|
14 |
bed to knife time
(1 time)
|
General Surgery (1 time)
|
LOS (1 time) OR (1 time)
|
2010 Management of acute appendicitis: the impact of CT scanning on the bottom line.
|
15 |
bee microbiome toolkit
(1 time)
|
Synthetic Biology (1 time)
|
---
|
2018 Genetic Engineering of Bee Gut Microbiome Bacteria with a Toolkit for Modular Assembly of Broad-Host-Range Plasmids.
|
16 |
between 'Black Tartarian' 'Kordia
(1 time)
|
Medicine (1 time)
|
LGs (1 time) SNPs (1 time)
|
2013 Construction and comparative analyses of highly dense linkage maps of two sweet cherry intra-specific progenies of commercial cultivars.
|
17 |
Bielinskas Test with Kuleszas modification
(1 time)
|
Public Health (1 time)
|
BMI (1 time) HDI (1 time) PCOS (1 time)
|
2017 Studies on the quality nutrition in women with polycystic ovary syndrome (PCOS)
|
18 |
Biomechanical ToolKit
(1 time)
|
Medical Informatics (1 time)
|
---
|
2014 Biomechanical ToolKit: Open-source framework to visualize and process biomechanical data.
|
19 |
black tea
(1 time)
|
Chemistry (1 time)
|
---
|
2008 Changes in free-radical scavenging ability of kombucha tea during fermentation.
|
20 |
black tea kombucha
(1 time)
|
Chemistry (1 time)
|
GTK (1 time) ZTK (1 time)
|
2021 Zijuan tea- based kombucha: Physicochemical, sensorial, and antioxidant profile.
|
21 |
Bruton kinase inhibitors
(1 time)
|
Hematology (1 time)
|
allo-SCT (1 time) CAR (1 time) CLL (1 time)
|
2023 CAR T-cell therapy for CLL: a new addition to our treatment toolbox?
|
22 |
Bruton non-receptor protein-tyrosine kinase
(1 time)
|
Pharmacology (1 time)
|
PH (1 time)
|
2016 Ibrutinib inhibition of Bruton protein-tyrosine kinase (BTK) in the treatment of B cell neoplasms.
|
23 |
Bruton protein-tyrosine kinase
(1 time)
|
Pharmacology (1 time)
|
PH (1 time)
|
2016 Ibrutinib inhibition of Bruton protein-tyrosine kinase (BTK) in the treatment of B cell neoplasms.
|
24 |
Bruton tyrosine kinase signaling
(1 time)
|
Hematology (1 time)
|
AF (1 time) BTKi (1 time)
|
2019 Management of adverse effects/toxicity of ibrutinib.
|
25 |
Bruton<apos;>s Tyrosine Kinase
(1 time)
|
Hematology (1 time)
|
CLL (1 time)
|
2022 Cardiotoxicity of BTK inhibitors: ibrutinib and beyond.
|
26 |
BTK gene
(1 time)
|
Genetics, Medical (1 time)
|
XLA (1 time)
|
2001 Maternal germinal mosaicism of X-linked agammaglobulinemia.
|
27 |
Buda Thermal Karst
(1 time)
|
Environmental Health (1 time)
|
---
|
2019 Natural radioactivity of thermal springs and related precipitates in Gellert Hill area, Buda Thermal Karst, Hungary.
|
28 |
described 'behind-the-knee
(1 time)
|
Dermatology (1 time)
|
---
|
2008 Evaluating lotion transfer to skin from feminine protection products.
|